Skip to main content

castration-resistant prostate cancer

News
07/13/2021
225Ac-J591 receives first human study with research in PSMA targeting and dose expansion capabilities during an ongoing phase I trial.
225Ac-J591 receives first human study with research in PSMA targeting and dose expansion capabilities during an ongoing phase I trial.
225Ac-J591 receives first human...
07/13/2021
Oncology
Research in Review
02/17/2017
JCP Editors
Taking one-fourth the recommended dose of a standard drug with a low-fat meal is as effective as taking the recommended dose on an empty stomach for patients with castration-resistant prostate cancer, according to...
Taking one-fourth the recommended dose of a standard drug with a low-fat meal is as effective as taking the recommended dose on an empty stomach for patients with castration-resistant prostate cancer, according to...
Taking...
02/17/2017
Journal of Clinical Pathways